Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson’s disease

Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson’s disease

(2010) Eduardo L. G. Moreira et al.   JOURNAL OF NEURAL TRANSMISSION

Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases

(2010) Takashi MURAMATSU   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

Risk is in the Air

(2009) Rui D. S. Prediger et al.   Annals of the New York Academy of Sciences

Midkine gene transfer protects against focal brain ischemia and augments neurogenesis

(2009) Eiichi Ishikawa et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson’s Disease

(2009) Rui D. S. Prediger et al.   NEUROTOXICITY RESEARCH

Dopaminergic hypofunctions and prepulse inhibition deficits in mice lacking midkine

(2009) Shintaro Ohgake et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Pleiotrophin receptor RPTP-ζ/β expression is up-regulated by l-DOPA in striatal medium spiny neurons of parkinsonian rats

(2008) Juan Esteban Ferrario et al.   JOURNAL OF NEUROCHEMISTRY